Matthew Nayor1, Vanessa Xanthakis2,3, Melissa Tanguay1, Jasmine B Blodgett1, Ravi V Shah1, Mark Schoenike1, John Sbarbaro1, Robyn Farrell1, Rajeev Malhotra1,4, Nicholas E Houstis1, Raghava S Velagaleti5, Stephanie A Moore5, Aaron L Baggish1, George T O'Connor6, Jennifer E Ho1,4, Martin G Larson, Ramachandran S Vasan3,7, Gregory D Lewis1,8. 1. Cardiology Division, Department of Medicine (M.N., M.T., J.B.B., R.V.S., M.S., J.S., R.F., R.M., N.E.H., A.L.B., J.E.H., G.D.L.), Massachusetts General Hospital, Harvard Medical School, Boston. 2. Department of Biostatistics, Boston University School of Public Health, MA (V.X.). 3. Section of Preventive Medicine and Epidemiology (V.X., R.S. Vasan), Department of Medicine, Boston University School of Medicine, MA. 4. Cardiovascular Research Center (R.M., J.E.H.), Massachusetts General Hospital, Harvard Medical School, Boston. 5. Cardiology Section, Department of Medicine, Boston VA Healthcare System, West Roxbury, MA (R.S. Velagaleti, S.A.M.). 6. Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine (G.T.O.), Department of Medicine, Boston University School of Medicine, MA. 7. Division of Cardiology (R.S. Vasan), Department of Medicine, Boston University School of Medicine, MA. 8. Pulmonary Critical Care Unit (G.D.L.), Massachusetts General Hospital, Harvard Medical School, Boston.
Abstract
BACKGROUND: Ventilatory efficiency (minute ventilation required to eliminate carbon dioxide, VE/VCO2) during exercise potently predicts outcomes in advanced heart failure with reduced ejection fraction, but its prognostic significance for at-risk individuals with preserved left ventricular systolic function is unclear. We aimed to characterize mechanistic determinants and prognostic implications of VE/VCO2 in a single-center dyspneic referral cohort (MGH-ExS [Massachusetts General Hospital Exercise Study]) and in a large sample of community-dwelling participants in the FHS (Framingham Heart Study). METHODS: Maximum incremental cardiopulmonary exercise tests were performed. VE/VCO2 was assessed as the slope pre- and post-ventilatory anaerobic threshold (VE/VCO2pre-VATslope, VE/VCO2post-VATslope), the slope throughout exercise (VE/VCO2overall-slope), and as the lowest 30-second value (VE/VCO2nadir). RESULTS: In the MGH-ExS (N=493, age 56±15 years, 61% women, left ventricular ejection fraction 64±8%), higher VE/VCO2nadir was associated with lower peak exercise cardiac output and steeper increases in exercise pulmonary capillary wedge pressure (both P<0.0001). VE/VCO2nadir (hazard ratio, 1.34 per 1-SD unit [95% CI, 1.10-1.62] P=0.003) was associated with future cardiovascular hospitalization/death and outperformed classical VE/VCO2 measures used in heart failure with reduced ejection fraction (VE/VCO2overall-slope). In FHS (N=1936, age 54±9 years, 53% women), VE/VCO2 measures taken in low-to-moderate intensity exercise (including VE/VCO2pre-VATslope, VE/VCO2nadir) were directly associated with cardiovascular risk factor burden (smoking, Framingham cardiovascular disease risk score, and lower fitness; all P<0.001). CONCLUSIONS: Impaired ventilatory efficiency is associated with cardiovascular risk in the community and with adverse hemodynamic profiles and future hospitalizations/death in a referral population, highlighting the prognostic importance of easily acquired submaximum exercise ventilatory gas exchange measurements in broad populations with preserved left ventricular systolic function.
BACKGROUND: Ventilatory efficiency (minute ventilation required to eliminate carbon dioxide, VE/VCO2) during exercise potently predicts outcomes in advanced heart failure with reduced ejection fraction, but its prognostic significance for at-risk individuals with preserved left ventricular systolic function is unclear. We aimed to characterize mechanistic determinants and prognostic implications of VE/VCO2 in a single-center dyspneic referral cohort (MGH-ExS [Massachusetts General Hospital Exercise Study]) and in a large sample of community-dwelling participants in the FHS (Framingham Heart Study). METHODS: Maximum incremental cardiopulmonary exercise tests were performed. VE/VCO2 was assessed as the slope pre- and post-ventilatory anaerobic threshold (VE/VCO2pre-VATslope, VE/VCO2post-VATslope), the slope throughout exercise (VE/VCO2overall-slope), and as the lowest 30-second value (VE/VCO2nadir). RESULTS: In the MGH-ExS (N=493, age 56±15 years, 61% women, left ventricular ejection fraction 64±8%), higher VE/VCO2nadir was associated with lower peak exercise cardiac output and steeper increases in exercise pulmonary capillary wedge pressure (both P<0.0001). VE/VCO2nadir (hazard ratio, 1.34 per 1-SD unit [95% CI, 1.10-1.62] P=0.003) was associated with future cardiovascular hospitalization/death and outperformed classical VE/VCO2 measures used in heart failure with reduced ejection fraction (VE/VCO2overall-slope). In FHS (N=1936, age 54±9 years, 53% women), VE/VCO2 measures taken in low-to-moderate intensity exercise (including VE/VCO2pre-VATslope, VE/VCO2nadir) were directly associated with cardiovascular risk factor burden (smoking, Framingham cardiovascular disease risk score, and lower fitness; all P<0.001). CONCLUSIONS: Impaired ventilatory efficiency is associated with cardiovascular risk in the community and with adverse hemodynamic profiles and future hospitalizations/death in a referral population, highlighting the prognostic importance of easily acquired submaximum exercise ventilatory gas exchange measurements in broad populations with preserved left ventricular systolic function.
Entities:
Keywords:
exercise; heart failure; physiology; population
Authors: Amanda B Methvin; Anjali T Owens; Anthony G Emmi; Michael Allen; Susan E Wiegers; Daniel L Dries; Kenneth B Margulies; Paul R Forfia Journal: Chest Date: 2010-08-05 Impact factor: 9.410
Authors: Gary J Balady; Ross Arena; Kathy Sietsema; Jonathan Myers; Lola Coke; Gerald F Fletcher; Daniel Forman; Barry Franklin; Marco Guazzi; Martha Gulati; Steven J Keteyian; Carl J Lavie; Richard Macko; Donna Mancini; Richard V Milani Journal: Circulation Date: 2010-06-28 Impact factor: 29.690
Authors: Daniel E Forman; Ross Arena; Rebecca Boxer; Mary A Dolansky; Janice J Eng; Jerome L Fleg; Mark Haykowsky; Arshad Jahangir; Leonard A Kaminsky; Dalane W Kitzman; Eldrin F Lewis; Jonathan Myers; Gordon R Reeves; Win-Kuang Shen Journal: Circulation Date: 2017-03-23 Impact factor: 29.690
Authors: Matthew Nayor; Ariel Chernofsky; Nicole L Spartano; Melissa Tanguay; Jasmine B Blodgett; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Raghava S Velagaleti; Joanne M Murabito; Martin G Larson; Ramachandran S Vasan; Ravi V Shah; Gregory D Lewis Journal: Eur Heart J Date: 2021-11-21 Impact factor: 35.855
Authors: Matthew Nayor; Ravi V Shah; Melissa Tanguay; Jasmine B Blodgett; Ariel Chernofsky; Patricia E Miller; Vanessa Xanthakis; Rajeev Malhotra; Nicholas E Houstis; Raghava S Velagaleti; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Am J Cardiol Date: 2021-08-12 Impact factor: 3.133
Authors: Jenna McNeill; Ariel Chernofsky; Matthew Nayor; Farbod N Rahaghi; Raul San Jose Estepar; George Washko; Andrew Synn; Ramachandran S Vasan; George O'Connor; Martin G Larson; Jennifer E Ho; Gregory D Lewis Journal: Eur Respir J Date: 2022-08-04 Impact factor: 33.795
Authors: Jingyi Gong; Renata R T Castro; Jesse P Caron; Camden P Bay; Jon Hainer; Alexander R Opotowsky; Mandeep R Mehra; Bradley A Maron; Marcelo F Di Carli; John D Groarke; Anju Nohria Journal: ESC Heart Fail Date: 2021-12-21
Authors: George A Alba; David R Ziehr; Jennifer N Rouvina; Lida P Hariri; Rachel S Knipe; Benjamin D Medoff; Kathryn A Hibbert; Alyssa Kowal; Casey Hoenstine; Leo C Ginns; Gregory D Lewis; C Corey Hardin Journal: EClinicalMedicine Date: 2021-08-28
Authors: Andrej Mazur; Kristian Brat; Pavel Homolka; Zdenek Merta; Michal Svoboda; Monika Bratova; Vladimir Sramek; Lyle J Olson; Ivan Cundrle Journal: PLoS One Date: 2022-08-12 Impact factor: 3.752
Authors: Matthew Nayor; Ravi V Shah; Patricia E Miller; Jasmine B Blodgett; Melissa Tanguay; Alexander R Pico; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Amy Deik; Kerry A Pierce; Kevin Bullock; Lucas Dailey; Raghava S Velagaleti; Stephanie A Moore; Jennifer E Ho; Aaron L Baggish; Clary B Clish; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Circulation Date: 2020-09-15 Impact factor: 29.690
Authors: Marco Guazzi; Barry Borlaug; Marco Metra; Maurizio Losito; Francesco Bandera; Eleonora Alfonzetti; Sara Boveri; Tadafumi Sugimoto Journal: J Am Heart Assoc Date: 2021-02-20 Impact factor: 5.501